Company intelligence / Profile preview

Piedmont Pharmaceuticals

Greensboro, North Carolina, United Statesbloomberg.com ↗

Ownership: Private
Employees: ~6
Development stage: Other

Overview

Piedmont Pharmaceuticals develops specialty therapeutics with a focus on parasitology and drug delivery systems for both human and animal health. The company has expertise in novel formulations such as injectable antibiotics, with several patents granted. In the veterinary sector, it has developed FDA-approved medications addressing unmet needs by improving compliance and ease of use. The company operates at various stages from R&D to commercialization, particularly strong in the animal health market.

Therapeutic areas: CardiovascularInfectious DiseasesOther
Modalities: Small moleculeDrug delivery systemsPotentially biologics
Industry: Biotech

Beyond the preview

Go deeper on Piedmont Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Piedmont Pharmaceuticals.

Explore the full profile